Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients

Project Details

AcronymR6416CNR
StatusActive
Effective start/end date01/08/2013 → …